Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
PA1-24769 detects RSK1 p90 (phospho S221) from human samples. PA1-24769 is expected to cross react with mouse (100% conserved) and rat (100% conserved) due to sequence homology. Cross reactivity with RSK2 is expected (100% conserved). Cross reactivity with RSK3 (80% homology) and RSK4 (90% homology) is possible but has not been tested. Not yet tested in other species.
PA1-24769 has been successfully used in Western blot procedures. A431 and NIH3T3 cells treated with PMA can be used as a positive control for this antibody.
The PA1-24769 immunogen is a synthetic phosphopeptide corresponding to a portion of human RSK1 containing serine 221.
Store at 4C short term. For extended storage, aliquot and store at -20C or below, avoiding freeze-thaw cycles.
RPS6KA1 (RSK1) is a growth-factor regulated serine/threonine kinase that is involved in the MAPK cascade. It is thought to control cellular proliferation and differentiation through the phosphorylation of transcription factors. RPS6KA1 contains 2 nonidentical kinase catalytic domains and phosphorylates various substrates, including members of the mitogen-activated kinase (MAPK) signalling pathway. The activity of this protein has been implicated in controlling cell growth and differentiation. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.
仅用于科研。不用于诊断过程。未经明确授权不得转售。